bpc-157 human trials 2025 🙋🏻‍♂️ Is the lack of data in a red flag? • If a drug could actually knit torn tendons back together in weeks, a trillion-dollar pharmaceutical industry probably wouldn't bury bpc-157 fda approval status 2025

Retatrutide E_max at GIPR 103%, GLP-1R 110%, GCGR 104% of native peptide peak (full agonist at all three at cAMP signaling per the conclusions section: "LY3437943 is a full agonist at the GCGR, GIPR, and GLP-1R in the functional assays")

Current compounding status As of March 2025, the FDA determined that the tirzepatide shortage is resolved, which impacts compounding eligibility

The cost of one wasted vial is trivial compared to the consequences of consistent over or under-dosing across weeks of your protocol

Until these are completed and regulatory approval is granted, retatrutide cannot be prescribed or legally supplied in the UK